Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- REGULATORY NEWS IN BRIEF
April 8, 2002
- Sankyo Transfers Development of Glaucoma Drug to Santen
April 8, 2002
- Elimination of Prescription Period Limitation Should Help Bungyo : Expert
April 8, 2002
- Nippon Shinyaku to Market HIGA Mice via Japan SLC
April 8, 2002
- Final Draft GL for Acute Pancreatitis Presented by JSAEM
April 8, 2002
- Otsuka, Otsuka Pharm Factory, Snow Brand Milk Create JV for Clinical Nutrition
April 8, 2002
- Korosho to Construct Critical Path-Sharing System
April 8, 2002
- Major Maker's New Invoice Prices Are More Acceptable than Before: Suzuken
April 8, 2002
- Doctors' Participation in Clinical Trial Training Disappointing
April 8, 2002
- BUSINESS NEWS IN BRIEF
April 8, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
April 8, 2002
- WEBSITE NEWS
April 8, 2002
- Novartis Kao to Be Dissolved
April 8, 2002
- EFPIA Japan to Strengthen European Makers' Presence
April 8, 2002
- Pola Cosmetics Transfers Food Division to Asahi Beer Pharm
April 8, 2002
- Committee Members Criticize Korosho's Healthcare Reform Bill
April 8, 2002
- Pharmarise to Develop Private Brand Supplements
April 8, 2002
- Monkasho to Create WG on Duality of Interest
April 8, 2002
- WSMI Congress to Be Held in Tokyo in November
April 8, 2002
- NEDO Selects Two Medical Device Projects for Funding
April 8, 2002
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…